Stay updated on Isatuximab Combo in High-Risk Smoldering MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.

Latest updates to the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page
- Check3 days agoChange DetectedThe Dec. 5, 2025 version of the study record now lists References among its changes. An NIH notice about the transition from “AI” to “SI” also appears at the top of the page.SummaryDifference0.5%

- Check10 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check17 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check38 days agoChange DetectedThe history list now shows a newer revision tag, v3.7.0, replacing the previous v3.6.6 tag, indicating an update to the page's revision history.SummaryDifference0.1%

- Check59 days agoChange DetectedThe study record history now includes a new revision entry v3.6.6, replacing the previous v3.6.5 entry in the revision list.SummaryDifference0.1%

- Check81 days agoChange DetectedA new release note entry 'Revision: v3.6.5' was added to the page history. The entries for 'References' and the previous 'Revision: v3.6.4' were removed from the history listing.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Combo in High-Risk Smoldering MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.